LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Kivitz, Alan [1 ]
Wells, Alvin F. [2 ]
Vargas, Juan I. [3 ]
Baraf, Herbert S. B. [4 ]
Rischmueller, Maureen [5 ]
Klaff, Justin [6 ]
Khan, Nasser [6 ]
Li, Yihan [6 ]
Carter, Kyle [6 ]
Friedman, Alan [6 ]
Durez, Patrick [7 ]
机构：
[1] Altoona Ctr Clin Res, Altoona Arthrit & Osteoporosis Ctr, Duncansville, PA USA
[2] Rheumatol & Immunotherapy Ctr, Rheumatol, Franklin, WI USA
[3] Quantum Res, Puerto Varas, Chile
[4] George Washington Univ, Rheumatol, Washington, DC USA
[5] Univ Adelaide, Inflammatory Rheumat Dis, Adelaide, Australia
[6] AbbVie, Immunol, N Chicago, IL USA
[7] Inst Rech Expt & Clin, Rheumatol, Brussels, Belgium
来源：
RHEUMATOLOGY | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P128
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Safety and efficacy of tofacitinib for up to 9.5years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Wollenhaupt, Juergen
    Lee, Eun-Bong
    Curtis, Jeffrey R.
    Silverfield, Joel
    Terry, Ketti
    Soma, Koshika
    Mojcik, Chris
    DeMasi, Ryan
    Strengholt, Sander
    Kwok, Kenneth
    Lazariciu, Irina
    Wang, Lisy
    Cohen, Stanley
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [12] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB (ABT-494), AN ORAL JAK-1 INHIBITOR IN PATIENTS WITH RHEUMATOID ARTHRITIS IN AN OPEN-LABEL EXTENSION STUDY
    Genovese, Mark C.
    Kremer, Joel
    Zhong, Sheng
    Friedman, Alan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S85 - S85
  • [13] Safety and Efficacy of Long-term Sarilumab Treatment in Patients with Active Rheumatoid Arthritis: EXTEND and MONARCH Open Label Extension Studies
    Burmester, Gerd
    Strand, Vibeke
    Kivitz, Alan
    Hu, Chih-Chi
    Wang, Sheldon
    van Hoogstraten, Hubert
    Tao, Ray
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3521 - 3525
  • [14] LONG-TERM SAFETY AND EFFICACY OF OLOKIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS - RESULT OF AN OPEN-LABEL EXTENSION STUDY, CREDO4
    Feist, E.
    Nasonov, E.
    Luggen, M.
    Fatenejad, S.
    Grishin, S.
    Samsonov, M.
    Fleischmann, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 593 - 593
  • [15] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis.
    Keystone, Edward C.
    Taylor, Peter C.
    Genovese, Mark C.
    Schlichting, Douglas E.
    De La Torre, Inmaculada
    Beattie, Scott D.
    Rooney, Terence
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1232 - S1232
  • [16] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine I.
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rizo Rodriguez, Juan Cruz
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571
  • [17] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine I.
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rizo Rodriguez, Juan Cruz
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1561 - 1571
  • [18] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [19] Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
    Westhovens, Rene
    Winthrop, Kevin L.
    Kavanaugh, Arthur
    Greenwald, Maria
    Dagna, Lorenzo
    Cseuz, Regina
    Besuyen, Robin
    de Vries, Dick
    Modgill, Vikas
    Le, Ly Huong
    Genovese, Mark C.
    Emery, Paul
    Verschueren, Patrick
    Alten, Rieke
    RMD OPEN, 2025, 11 (01):
  • [20] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Nash, Peter
    Coates, Laura C.
    Kivitz, Alan
    Mease, Philip J.
    Gladman, Dafna D.
    Covarrubias-Cobos, Jose A.
    Fitzgerald, Oliver
    Fleishaker, Dona
    Wang, Cunshan
    Wu, Joseph
    Hsu, Ming-Ann
    Menon, Sujatha
    Fallon, Lara
    Romero, Ana Belen
    Kanik, Keith S.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 553 - 580
12345